EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo



RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo



Plos One 6(10): E25352-E25352



Peptides containing the RGD sequence are under continuous investigation given their ability to control cell adhesion and apoptosis. Since small peptides are quickly metabolized and degraded in vivo, developing analogs resistant to serum-induced degradation is a challenging task. RGD analogs developed so far are known as molecules mostly inhibiting cell adhesion; this feature may reduce cell proliferation and tumor development but may not induce regression of tumors or metastases already formed. In the current study, carried out in melanoma in vitro and in vivo models, we show that RAM, an RGD-non-peptide Analog-Molecule, strongly inhibits cells adhesion onto plastic, vitronectin, fibronectin, laminin and von Willebrand Factor while it does not inhibit cell adhesion onto collagen IV, similarly to the RGDS template peptide. It also strongly inhibits in vitro cell proliferation, migration and DNA-synthesis, increases melanoma cells apoptosis and reduces survivin expression. All such effects were observed in collagen IV seeded cells, therefore are most likely independent from the anti adhesive properties. Further, RAM is more stable than the template RGDS; in fact it maintains its anti-proliferation and anti-adhesion effects after long serum exposure while RGDS almost completely loses its effects upon serum exposure. In a mouse metastatic melanoma in vivo model, increasing doses of RAM significantly reduce up to about 80% lung metastases development, while comparable doses of RGDS are less potent. In conclusion these data show that RAM is a potent inhibitor of melanoma growth in vitro, strongly reduces melanoma metastases development in vivo and represents a novel candidate for further in vivo investigations in the cancer treatment field.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333072

Download citation: RISBibTeXText

PMID: 21984914

DOI: 10.1371/journal.pone.0025352



Related references

KD7150, a novel mercaptoketone-based HDAC inhibitor, exerts potent anti-multiple myeloma effects in vitro and in vivo by induction of DNA damage and mitochondrial signaling. 2007

Psychotropic agent thioridazine elicits potent in vitro and in vivo anti-melanoma effects. Biomedicine & PharmacoTherapy 97: 833-837, 2017

A novel RGDS-analog inhibits angiogenesis in vitro and in vivo. Biochemical and Biophysical Research Communications 321(4): 809-814, 2004

YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo. Cancer ChemoTherapy and Pharmacology 77(6): 1217-1229, 2016

The mitochondrion interfering compound NPC-26 exerts potent anti-pancreatic cancer cell activity in vitro and in vivo. Tumour Biology 37(11): 15053-15063, 2016

NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model. Cancer Letters 414: 88-98, 2017

A novel and potent Syk inhibitor exerts effects in vitro and in vivo in a stereoselective manner. Inflammation Research 52(Supplement 2): S 157, July, 2003

MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro. Journal of Steroid Biochemistry and Molecular Biology 155(Pt A): 26-34, 2016

A zinc chelator inhibiting gelatinases exerts potent in vitro anti-invasive effects. European Journal Of Pharmacology. 351(2): 225-233, E, 1998

Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead, II. Bioorganic & Medicinal Chemistry Letters 20(10): 3047-3049, 2010

TXA9, a cardiac glycoside from Streptocaulon juventas, exerts a potent anti-tumor activity against human non-small cell lung cancer cells in vitro and in vivo. Steroids 94: 51-59, 2015

Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling. International Journal of Molecular Sciences 19(6): -, 2018

PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo. Plos One 11(9): E0161730-E0161730, 2017

Diayangambin exerts immunosuppressive and anti-inflammatory effects in vitro and in vivo. Planta Medica 68(12): 1128-1131, 2002

D. candidum has in vitro anticancer effects in HCT-116 cancer cells and exerts in vivo anti-metastatic effects in mice. Nutrition Research and Practice 8(5): 487-493, 2014